Reovirus activates human dendritic cells to promote innate antitumor immunity. - Wikidata - wikimedia - TriplyDB

Reovirus activates human dendritic cells to promote innate antitumor immunity.

Reovirus activates human dendritic cells to promote innate antitumor immunity.

http://www.wikidata.org/entity/Q39990406

about

Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Thunder and lightning: immunotherapy and oncolytic viruses collide Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Going viral: a review of replication-selective oncolytic adenoviruses Emerging role of Natural killer cells in oncolytic virotherapy Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors Modification of mammalian reoviruses for use as oncolytic agents A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives Impact of tumor microenvironment on oncolytic viral therapy Enteric reovirus infection stimulates peanut-specific IgG2a responses in a mouse food allergy model.Trends in cancer immunotherapy NK-cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by parvovirus infection of target cells.Oncolytic reovirus in canine mast cell tumor.Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites Proteolytic disassembly of viral outer capsid proteins is crucial for reovirus-mediated type-I interferon induction in both reovirus-susceptible and reovirus-refractory tumor cells.Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles.Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.Oncolytic reovirus synergizes with chemotherapeutic agents to promote cell death in canine mammary gland tumor Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia.Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.Reovirus in cancer therapy: an evidence-based review Tumor infection by oncolytic reovirus primes adaptive antitumor immunity.Oncolytic viruses: a novel form of immunotherapy.Reovirus: a targeted therapeutic--progress and potential.Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms.Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells Reovirus-based therapy for cancer.The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.Maraba virus as a potent oncolytic vaccine vector.REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer.The evolving role of dendritic cells in cancer therapy.Orthoreovirus outer-fiber proteins are substrates for SUMO-conjugating enzyme Ubc9.Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.

P2860

Q24596171-B421ED95-FE4E-4CFF-8244-F11A86C9D99B Q24597894-C4FFA17E-2683-49DB-BD98-A917208147C0 Q24611483-DA8D76D4-F557-4AA2-8ED0-734B1C2E81C6 Q26750568-8C60CC53-54BE-47A1-A722-E9A4550026A1 Q26752807-1BEA8DF1-0556-4F6B-A21E-C989180BB6DE Q26774345-114E6F28-A5F2-4AAF-AFB1-C882E4B679D9 Q26775030-533BA4C7-6650-4865-909F-0E5BC67CA4AD Q26797520-D4168618-0E2B-4A7C-9BF2-55D5CC72621F Q27025330-BFF39098-7465-4E7D-BF45-B2B21300B421 Q28086999-0724A35D-4D10-4EE0-9FE0-41A38B0BBE46 Q28264900-750FE32D-4C39-4476-81F1-E328AA2B33C0 Q33418048-8F0F91B9-1F89-4A65-94FC-9A5DC3FB9269 Q33679505-ED4ED59B-F401-4FBA-A8B7-3D96074BBB6A Q33895533-89716918-C63B-464F-B430-133A7109AFC9 Q34014468-4A426559-FF59-4DA2-B3FE-15547BD9EB49 Q34052702-4CE22277-7634-42F2-A431-401ED05EBB5A Q34884713-A1BD8167-4E30-48DE-BE62-41D7A4C8FE2E Q35000631-FDACB191-9FD5-480E-9525-A8190972F21C Q35061974-CC73DAB6-B7B8-40E1-AD91-57F9956B9869 Q35249529-C5F9203E-C9A2-4A23-860C-952AB1FA9630 Q35653886-B1D06542-539D-4296-AE04-21EB7427470D Q35812675-58DDA194-7AE1-48A3-BCA9-ED9360793144 Q36390114-CB3C9B33-428F-4758-BFE5-CEBBA60E58D3 Q36574519-E31B64E4-B8E4-4F85-B46E-206BD8DA7657 Q36582819-CCFAB2F2-B025-4E1E-93AB-B7ABA8A49CAD Q36673709-2777C801-848B-457E-A9A4-E9B690DBA294 Q36890816-AD276A29-6DFB-4993-AD18-74992C5AA164 Q37031909-EDB429F0-6B8D-405B-A30B-1C7A4612B182 Q37239555-B5EDDFD1-3108-4E34-B4AA-1A81F6783A75 Q37300008-1DD0C0F2-9E08-420A-AFF3-D4775DDFA214 Q37360608-E515BC8C-14F9-402B-ACF7-287B1B82FA53 Q37459636-2BB144F7-C105-446E-988F-086B506604BC Q37477574-1BDB0554-220B-451F-91A0-C92D218F49F5 Q37519640-3CCB6995-22A3-43EA-A9E7-B20B6872AEA6 Q37561072-3A4EDDDA-0454-4ED0-9D9B-9B400DF0856E Q37562080-8F1BA19A-51A6-4C14-BE33-166F51C6AFE3 Q37602536-0F50CC9C-1A1E-447F-9CCB-999C0C797527 Q37687418-F0217B04-EA96-4146-AA82-6B73F684E8AC Q37694854-092B9831-DED3-4AF1-B3EE-4DF516484C69 Q37707676-1D3B7AC2-0C44-4E83-8FA5-4F9BF1ADE0AA

P2860

Reovirus activates human dendritic cells to promote innate antitumor immunity.

http://www.wikidata.org/entity/Q39990406

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@en

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@en-gb

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@nl

type

label

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@en

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@en-gb

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@nl

prefLabel

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@en

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@en-gb

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@nl

P1433

Q39990406-9CB812D5-695D-4281-B972-2213703D207B

P1476

Q39990406-34B38710-BD44-43CC-87FB-AEF39504067B

P2093

Q39990406-0BA89C38-696E-41E1-AF6A-BB00966FE072

Q39990406-0DAD7C87-AB3A-408C-8E72-477643939D53

Q39990406-86B05A78-6523-4470-AE6E-A42190C37632

Q39990406-96932873-864F-45F0-99FE-AD7ACE72A1E7

Q39990406-9E9BEBBE-3E2A-4FB2-8077-BFFB7668249E

Q39990406-A0A0D721-3A2B-4B38-885C-A9A6AF5D58FB

Q39990406-A5954435-D619-4E10-97FA-0C89BB89406E

Q39990406-C95145CC-AC63-4FEA-AB9A-3B71688E930A

Q39990406-E9517F71-1501-40E6-960D-ED6850F3F469

P304

Q39990406-CFA1811A-31BC-41E4-BE1A-39AFC4226499

P31

Q39990406-B39EEC7B-C77E-40B3-97AD-17B5E9E7827C

P356

Q39990406-47D26CBA-4008-455A-A686-E0638B44500A

P407

Q39990406-C9C677FE-0706-4708-842A-0D257F5158D2

P433

Q39990406-7E5D943F-E7BD-4E9C-AEA0-3F700D80BD29

P478

Q39990406-C63B6262-2283-4CEC-A62D-B66A987839D8

P50

Q39990406-08FC1315-828E-483F-9033-4582BC871A11

Q39990406-3CB967B4-83F7-4FE9-A25E-1D3D8285FEC1

P577

Q39990406-238DE4CA-41C2-4A23-894E-1D822E354345

P5875

Q39990406-AF7021A5-6FED-4A8E-8131-0CB3632667D5

P698

Q39990406-68944A96-868A-4E55-9A18-9A058C293C31

P356

JIMMUNOL.180.9.6018

P1433

Journal of Immunology

P1476

Reovirus activates human dendritic cells to promote innate antitumor immunity.

@en

P2093

Fiona Errington

http://www.w3.org/2001/XMLSchema#string

Hardev S Pandha

http://www.w3.org/2001/XMLSchema#string

Johann de Bono

http://www.w3.org/2001/XMLSchema#string

Kevin J Harrington

http://www.w3.org/2001/XMLSchema#string

Laura Vidal

http://www.w3.org/2001/XMLSchema#string

Lynette Steele

http://www.w3.org/2001/XMLSchema#string

Matt Coffey

http://www.w3.org/2001/XMLSchema#string

Richard Vile

http://www.w3.org/2001/XMLSchema#string

Robin Prestwich

http://www.w3.org/2001/XMLSchema#string

P304

6018-6026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.180.9.6018

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5427505

http://www.w3.org/2001/XMLSchema#string

P698

18424722

http://www.w3.org/2001/XMLSchema#string